The efficacy of cPED for TMA

JRCT ID: jRCTs022190024

Registered date:31/03/2020

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Thrombotic microangiopathy
• Date of first enrollment: 31/03/2020
• Target sample size: 5
• Study type: Interventional
• Intervention(s): cPED therapy

Outcome(s)

• Primary Outcome: Changes in platelet counts before and after cPED

Secondary Outcome

1. Incidence of adverse events.
2. Changes in blood test data before and after cPED.
3. Changes in severity assessment scores before and after cPED.
4. Number of days in ICU.
5. 28-day survival or discharge survival.

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: The thrombotic microangiopathy patients whose physician presume that plasma exchange is effective.
• Exclude criteria: Patients deemed inappropriate by the study director.

Related Information

• Primary Sponsor: Satoh Kasumi
• Secondary Sponsor: Nakae Hajime,Akita University Hospital